Dollar General, HP, Johnson & Johnson and More Friday Afternoon Analyst Calls

By Chris Lange Published May 28, 12:21PM EDT

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Dollar General, HP, Johnson & Johnson and More Friday Afternoon Analyst Calls — © JJ Gouin / iStock via Getty Images

With the trading day more than halfway over, the markets were moving higher going into the weekend. Each of the major indexes posted a gain of at least 0.4% on a strong push from the tech sector. This is also a welcome move from the dip that investors saw last week.

24/7 Wall St. is reviewing some big analyst calls seen on Friday. We have included the latest analyst call on each stock, as well as a recent trading history and the consensus targets among analysts.

For those that might have missed it, 24/7 Wall St. had an earlier round of analyst calls on Thursday that included Apple, Best Buy, Costco, Intel and more.

Adaptimmune Therapeutics PLC (NASDAQ: ADAP): Barclays initiated coverage with an Underweight rating with a $4 price target. Shares were trading around $5, in the 52-week range of $3.79 to $13.40. The consensus price target is $11.33.

[nativounit]

Dollar General Corp. (NYSE: DG | DG Price Prediction): Telsey Advisory reiterated an Outperform rating and raised the price target to $235 from $225. The shares traded near $206 on Thursday, in a 52-week trading range of $173.50 to $225.25. The consensus price target is $235.78.

Guess Inc. (NYSE: GES): Telsey Advisory reiterated a Market Perform rating and raised the price target to $33 from $27. The stock traded near $29 on Thursday, in a 52-week range of $8.40 to $31.12. It has a consensus price target of $30.00.

HP Inc. (NYSE: HPQ): Cowen reiterated a Market Perform rating and raised the price target to $30 from $27. On Thursday, the stock traded around $29. The 52-week trading range is $14.86 to $36.00. The consensus price target is $32.43.

Johnson & Johnson (NYSE: JNJ): Morgan Stanley resumed coverage with an Overweight rating and a $187 price target. The stock traded near $170 on Thursday, in a 52-week range of $133.65 to $173.65. It has a consensus price target of $186.65.

Teladoc Health Inc. (NYSE: TDOC): Robert Baird initiated coverage with a Neutral rating and a $162 price target. The stock was changing hands at roughly $153 on Thursday, in a 52-week range of $129.74 to $308.00. It has a consensus price target of $231.41.

[recirclink id=888494]
Four recently public stocks have had some wild price swings in 2021, but they are rated Buy across Wall Street and offer stellar technologies and applications. They also offer excellent entry points and have posted some solid results so far.

[wallst_email_signup]

About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.